Pulmonary retention of free and liposome-encapsulated tobramycin after intratracheal administration in uninfected rats and rats infected with Pseudomonas aeruginosa.

Omri, A; Beaulac, C; Bouhajib, M; Montplaisir, S; Sharkawi, M; Lagacé, J

Omri, A; Beaulac, C; Bouhajib, M; Montplaisir, S; Sharkawi, M; Lagacé, J.

Affiliation

Omri A; Département de Microbiologie, Faculté de Médecine, Université de Montréal, Québec, Canada.

Antimicrob Agents Chemother ; 38(5): 1090-5, 1994 May.

Article in En | MEDLINE | ID: mdl-8067743

Subject(s)

Lung/metabolism; Pseudomonas Infections/metabolism; Tobramycin/pharmacokinetics; Animals; Drug Carriers; Intubation, Intratracheal; Liposomes; Lung/microbiology; Male; Pseudomonas Infections/drug therapy; Pseudomonas Infections/microbiology; Rats; Rats, Sprague-Dawley; Tobramycin/administration & dosage; Tobramycin/therapeutic use

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pseudomonas Infections / Tobramycin / Lung Limits: Animals Language: En Journal: Antimicrob Agents Chemother Year: 1994 Document type: Article Affiliation country: Canada

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google